Latest News & Updates
A new phase begins for Thomas Neville, PhD, a Yale and Stanford-trained engineer and economist who worked in energy before a prostate cancer diagnosis drew him into medical research.
The role of mTOR inhibition in breast cancer is evolving, and ongoing studies are evaluating biomarkers that will identify the patients who will benefit.
Older, single white males with advanced bladder cancer have the highest suicide risk among those with other cancers of the male genitals and urinary system, researchers report.
A bill to repeal the SGR formula garnered critical support with a vote by the House of Representatives.
In an interview with OncLive, William G. Wierda, MD, PhD, discusses the changing role of chemotherapy in the management of CLL and the integration of novel agents into clinical practice.
Latest Peer Exchange Discussions
Panelists discuss the importance of urology practices being involved in clinical trials, for both patients and physicians. View Now
Mark A. Socinski, MD, describes the growing potential of immunotherapy in non-small cell lung cancer. View Now
R. Michael Tuttle, MD, describes the evolution of risk stratification and how risk assessment is used to determine optimal treatment. View Now
In this segment, Dean F. Bajorin, MD, comments on treatment approaches for muscle-invasive bladder cancer. View Now
Most Popular Right Now
Online CME Activities